ENTITY

BrainStorm Cell Therapeutics I (BCLI US)

4
Analysis
Health CareUnited States
BrainStorm Cell Therapeutics Inc. is a biotechnology company developing autologous adult stem cell therapies for neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS) and Parkinson's disease (PD).
more
Refresh
Publication Icon
No publications yet
There aren’t any buy-side reports right now
Back to "All"
x